We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Fifth webinar in the Webinar Series of the Joint Knowledge Transfer Framework for Food Standards and Food Safety Analysis on 29 March 2023
The Medicines and Healthcare products Regulatory Agency has issued an opinion on the regulatory status of products containing CBD
This document contains the following information: Government Response to the House of Lords Select Committee on Science and Technology's Report on Therapeutic Uses of Cannabis.
First published during the 2001 to 2005 Labour government
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001.
Specialist clinicians will be able to legally prescribe cannabis-derived medicinal products by the autumn, Home Secretary Sajid Javid announced today.
FOI 3589 We received a request under the Freedom of Information Act 2000 for to release all documents/information relating to the decision …
Request for details of the background that led to David Blunkett's decision to downgrade cannabis from a class B drug to a class C drug.
SIA response to a Freedom of Information (FOI) request for confirmation of whether SIA licence-linked training covers the possession of medical cannabis.
Home Secretary to receive advice on cannabis-related medicinal products.
The nil response to an FOI asking for information about how to obtain a licence for growing cannabis and how many the CNC has issued
The Home Secretary today announced a review into the scheduling of cannabis for medicinal purposes.
Patients prescribed cannabis-based medicines will be able to get their treatment in days rather than months.
Cannabis-based products for medicinal use will be available for specialist doctors to prescribe legally.
Home Secretary writes to the chair of the Advisory Council on the Misuse of Drugs about scheduling of cannabis-derived medicinal products.
Letter from Kit Malthouse MP to Professor Owen Bowden-Jones, Chair of the Advisory Council on the Misuse of Drugs (ACMD).
A letter to clinicians from the Chief Medical Officer and NHS England following the rescheduling of legislation to allow the medicinal use of cannabis-based products.
CNC nil return response to an FOI about people charged with possession of cannabis
The number of people charged with cultivation or production of cannabis.
Home Secretary responds to the recommendations of the Advisory Council on the Misuse of Drugs about scheduling of cannabis-derived medicinal products.
Poisons specialists have flagged rises in calls and online queries about treating users of new psychoactive substances, misleadingly known as ‘legal highs’.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.